The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3700
Last updated 2012-03-14
Summary
Collect the real clinical background of advanced colorectal cancer c of China.
Conditions
- Advanced Malignant Neoplasm
- Colorectal Cancer
Sponsors & Collaborators
-
Chinese Medical Doctor Association
lead OTHER
Principal Investigators
-
Lin Shen, MD · Peking University Cancer Hospital & Institute
-
Ruihua Xu, MD, PhD · Sun Yat-sen University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- China
Study Locations
More Related Trials
-
Observational Study on the Patients With Rectal Cancer
NCT02312284 ·Status: COMPLETED
-
Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NCT06637215 ·Status: RECRUITING ·Phase: NA
-
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
NCT05871762 ·Status: RECRUITING
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING
-
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
NCT05023720 ·Status: UNKNOWN
-
Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer
NCT03142282 ·Status: UNKNOWN ·Phase: PHASE2
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
Effects of Different Treatment for Anorectal Function of Patients With Rectal Cancer
NCT05671809 ·Status: NOT_YET_RECRUITING
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis
NCT02912052 ·Status: UNKNOWN ·Phase: PHASE3
-
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors
NCT06185907 ·Status: COMPLETED
-
Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients
NCT02149784 ·Status: UNKNOWN ·Phase: PHASE3
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
NCT06115837 ·Status: COMPLETED
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
NCT05635149 ·Status: UNKNOWN
-
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
NCT04714814 ·Status: UNKNOWN
-
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
NCT04917289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 ·Status: ACTIVE_NOT_RECRUITING
-
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866 ·Status: ENROLLING_BY_INVITATION
-
Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
NCT05962502 ·Status: RECRUITING ·Phase: PHASE2
-
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
NCT03725254 ·Status: UNKNOWN ·Phase: PHASE2